Massimo Di Maio, Associate Professor of Medical Oncology at Department of Oncology at University of Turin, shared a post on X, about an article that He and His colleagues co-authored in Sage Journals:
“Even within the same country (Italy), use of off-label cancer drugs is subject to significant inter-hospital variability.
This leads to potential disparities in patients’ access to care.
Have a look at the project by AIOM, just published on Tumori Journal.”
Title: Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica.
Authors: Anna Amela Valsecchi, Matilde Scaldaferri, Marcello Tiseo, Gianmauro Numico, Gianluca Russo, Nicola Personeni, Livio Blasi, Alessia Pisterna, Alessandra Zanardi, Claudia Fruttero, Giordano Domenico Beretta, Giulia Dusi, Marina Campione, Alessandra Gennari, Maria Rachele Chiappetta, Francesco Perrone, Massimo Di Maio
Read the full article on Sage Journal
More posts featuring Massimo Di Maio on OncoDaily.
